1. What Is a Receptor Occupancy Model?
Receptor occupancy models describe the relationship between the concentration of a drug and the fraction of available receptors that are occupied by that drug. They provide one of the simplest mechanistic bridges between pharmacokinetics and pharmacodynamics.
The central idea is straightforward: as drug concentration increases, more receptors become occupied, but occupancy generally approaches an upper limit because the available binding sites are finite.
A receptor occupancy relationship is typically saturable: occupancy increases with concentration and approaches the fraction of receptors that can be occupied.
2. The Basic Receptor-Binding Model
Consider a drug, denoted \(D\), binding reversibly to a receptor, denoted \(R\), to form a drug-receptor complex \(DR\):
The forward reaction represents binding of drug to an available receptor, while the reverse reaction represents dissociation of the drug-receptor complex.
Under a simple equilibrium-binding model, the fraction of receptors occupied by drug is described by the concentration of free drug relative to the binding affinity.
The classical occupancy equation is:
where \(C\) is the relevant free drug concentration and \(K_D\) is the equilibrium dissociation constant.
The equation produces a bounded response: when \(C\) is very small relative to \(K_D\), occupancy is low; when \(C\) is much larger than \(K_D\), occupancy approaches one.
3. What Does \(K_D\) Mean?
\(K_D\), the equilibrium dissociation constant, is a parameter describing the affinity of the drug for the receptor in the specified binding system.
For the simple one-site equilibrium model, \(K_D\) has an especially useful interpretation. When the free drug concentration equals \(K_D\), the occupancy is 50%:
Thus, \(K_D\) is the concentration at which half of the available receptors are occupied under the assumptions of the model.
| Relationship | Approximate occupancy |
|---|---|
| \(C \ll K_D\) | Much less than 50% |
| \(C=K_D\) | 50% |
| \(C=3K_D\) | 75% |
| \(C=9K_D\) | 90% |
| \(C\gg K_D\) | Approaches 100% |
A smaller \(K_D\) means that a lower free drug concentration is required to achieve a given occupancy, within the same model and experimental context.
4. From Fractional Occupancy to Number of Bound Receptors
The occupancy equation describes a fraction. If the total concentration or number of available receptors is \(R_{\mathrm{tot}}\), the amount of receptor-bound drug can be represented as:
This equation separates two ideas: the shape of the concentration-occupancy relationship and the total amount of receptor available.
If \(R_{\mathrm{tot}}\) doubles while the free drug concentration and affinity remain unchanged, the fractional occupancy remains unchanged, but the absolute amount of receptor-bound drug increases.
5. Why Is Receptor Occupancy Saturable?
The saturable shape follows directly from the finite number of receptor binding sites.
At low concentrations, increasing drug concentration can produce a substantial increase in occupancy because many receptors remain unoccupied. As concentration rises, fewer binding sites remain available, so each additional increase in concentration produces a progressively smaller increase in occupancy.
For the simple one-site model, \(K_D\) corresponds to 50% receptor occupancy.
This saturability is an important mechanistic feature. It distinguishes receptor binding models from purely linear concentration-effect relationships.
6. Receptor Occupancy Is Not the Same as Pharmacologic Effect
One of the most important concepts in PK/PD modeling is that binding and effect are related but distinct processes.
A receptor occupancy model describes how much target is bound. A pharmacodynamic model describes how that binding translates into an observed response.
The relationship between occupancy and effect may be approximately proportional in some systems, but it can also be nonlinear. Factors such as receptor reserve, downstream amplification, constitutive activity, signal transduction, and feedback can affect the occupancy-effect relationship.
| Quantity | Question |
|---|---|
| Drug concentration | How much free drug is present? |
| Receptor occupancy | What fraction of receptors is bound? |
| Receptor activation | What functional state does binding produce? |
| Downstream signal | What cellular or molecular response follows? |
| Observed effect | What measurable pharmacodynamic endpoint results? |
7. Connecting Receptor Occupancy to an \(E_{\max}\) Model
A simple way to connect receptor occupancy to effect is to assume that the pharmacologic response is proportional to the occupied receptor fraction.
If \(E_0\) is baseline effect and \(E_{\max}\) represents the maximum effect attributable to the receptor-mediated component, one possible formulation is:
This has the same mathematical form as a simple \(E_{\max}\) model.
Under this particular assumption, the concentration producing 50% of the maximal receptor-mediated component is \(K_D\).
8. Why \(K_D\) and \(EC_{50}\) Are Not Automatically the Same
\(K_D\) describes binding affinity in the specified receptor-binding model. \(EC_{50}\) describes the concentration associated with 50% of a defined maximal pharmacodynamic response.
These parameters can be numerically similar in a simple direct-effect system, but they answer different questions.
| Parameter | Describes | Typical context |
|---|---|---|
| \(K_D\) | Equilibrium binding affinity | Receptor-binding experiment or occupancy model |
| \(EC_{50}\) | Concentration producing 50% of maximal observed effect | Concentration-effect model |
| \(K_i\) | Inhibition/binding affinity parameter in an appropriate competition model | Competitive binding or inhibition studies |
Differences can arise because receptor activation is not necessarily proportional to occupancy and because downstream biology can amplify, attenuate, or otherwise transform the binding signal.
9. Competitive Binding and Multiple Ligands
Receptors may interact with more than one ligand. When two compounds compete for the same binding site, the occupancy of one ligand depends not only on its own concentration and affinity but also on the concentration and affinity of the competing ligand.
A conceptual competitive occupancy expression for ligand \(A\) is:
Here, \(C_A\) and \(C_B\) are free concentrations of two competing ligands and \(K_{D,A}\) and \(K_{D,B}\) describe their respective affinities under the model.
As the concentration of competitor \(B\) increases, the predicted occupancy of \(A\) decreases when the compounds compete for the same receptor site.
10. From Static Binding to Time-Varying Occupancy
The equilibrium equation can be applied at each time point when binding is sufficiently rapid relative to changes in drug concentration:
This creates a direct bridge from a PK concentration-time profile to a predicted receptor-occupancy profile.
Because the occupancy relationship is nonlinear, receptor occupancy does not necessarily change proportionally with concentration.
For example, a large increase in concentration at concentrations already far above \(K_D\) may produce only a small increase in occupancy because the receptors are already close to saturation.
11. When Equilibrium Binding Is Not Enough
The equilibrium occupancy equation assumes that receptor binding is effectively at equilibrium with respect to the concentration changes being modeled.
That assumption may be inadequate when association and dissociation are slow relative to the changing drug concentration.
A dynamic binding model can instead represent the amount of drug-receptor complex explicitly:
where:
- \(k_{\mathrm{on}}\) is the association rate constant.
- \(k_{\mathrm{off}}\) is the dissociation rate constant.
- \(C\) is the free drug concentration.
- \([R]\) is the concentration of unoccupied receptor.
- \([DR]\) is the concentration of drug-receptor complex.
Under the simple equilibrium framework, the affinity relationship can be expressed as:
This illustrates an important distinction: two drugs can have similar equilibrium affinity while having different association and dissociation kinetics.
12. Receptor Occupancy as a Target-Engagement Model
Receptor occupancy models are often used as simplified target-engagement models. The goal is to estimate or predict how much of a molecular target is engaged by drug exposure.
A conceptual PK-to-target-engagement sequence is:
This framework can help organize translational reasoning across preclinical and clinical studies.
For example, if a compound requires approximately 80% target occupancy for a desired biological effect in a particular experimental system, a PK model can be used to ask whether a proposed dosing regimen is expected to maintain concentrations associated with that occupancy.
13. Worked Example: Predicting Receptor Occupancy
Suppose a hypothetical drug has an equilibrium dissociation constant of \(K_D=10\) ng/mL. Assume the relevant free drug concentration at a particular time is \(C=30\) ng/mL.
Step 1: Write the occupancy model
Step 2: Insert the concentration and affinity
Step 3: Calculate occupancy
Step 4: Express as a percentage
The model therefore predicts approximately 75% receptor occupancy at a free drug concentration of 30 ng/mL.
Notice that the concentration is three times \(K_D\), not three times the occupancy. Because the relationship is saturable, three times \(K_D\) corresponds to 75% occupancy rather than 300% occupancy.
14. Linking Dose, PK, and Receptor Occupancy
A receptor occupancy model becomes especially useful when it is connected to a PK model.
Suppose a PK model predicts a concentration-time profile \(C(t)\). The occupancy model can transform that concentration profile into a target-engagement profile:
For a simple one-compartment IV bolus model:
Substitution gives:
This combined model shows how dose, clearance, volume of distribution, and receptor affinity can jointly determine predicted target engagement over time.
15. How Concentration and Affinity Affect Occupancy
The occupancy equation makes the roles of concentration and affinity explicit:
There are two particularly useful ways to increase occupancy within the model:
- Increase the free drug concentration \(C\).
- Decrease the dissociation constant \(K_D\), corresponding to greater affinity in the same binding framework.
| \(C/K_D\) | Predicted occupancy |
|---|---|
| 0.1 | 9.1% |
| 0.25 | 20.0% |
| 0.5 | 33.3% |
| 1 | 50.0% |
| 2 | 66.7% |
| 3 | 75.0% |
| 9 | 90.0% |
| 19 | 95.0% |
The table highlights a key property of saturable binding: achieving increasingly high occupancy requires progressively larger concentrations relative to \(K_D\).
16. What Concentration Is Required for a Desired Occupancy?
The occupancy equation can also be rearranged to determine the concentration associated with a specified target occupancy.
Starting with:
Solving for \(C\) gives:
This is useful when a target occupancy has been specified from independent pharmacological evidence.
For example, suppose the desired occupancy is 90% and \(K_D=10\) ng/mL:
Thus, under the simple equilibrium model, a free concentration of approximately 90 ng/mL is associated with 90% occupancy.
17. What Can Make Occupancy Vary Between Individuals?
Observed target engagement can vary between individuals for several reasons. Some affect drug concentration, while others affect the relationship between concentration and binding.
| Source | Potential influence |
|---|---|
| Clearance | Changes systemic exposure and therefore the concentration available for binding |
| Bioavailability | Changes the fraction of an administered dose reaching systemic circulation |
| Protein binding | Can affect the free concentration available for receptor interaction |
| Receptor expression | Can alter the absolute amount of target available |
| Target affinity | Changes the concentration-occupancy relationship |
| Concomitant ligands | May alter occupancy through competitive binding |
| Binding kinetics | May cause occupancy to lag behind changing concentration |
A population PK/PD framework can incorporate some of these sources of variability explicitly, provided the available data contain sufficient information to estimate the relevant parameters.
18. Limitations and Assumptions of Receptor Occupancy Models
The simple occupancy equation is powerful because it is simple, but that simplicity comes from assumptions.
- Equilibrium assumption. The binding process is assumed to reach equilibrium sufficiently quickly relative to concentration changes.
- Single-site behavior. The basic equation represents a simple binding site without explicitly modeling multiple classes of binding sites.
- Constant affinity. \(K_D\) is treated as a stable parameter within the modeled system.
- Free concentration matters. The concentration relevant to receptor binding may be the unbound concentration at the target site rather than total plasma concentration.
- Occupancy is not automatically effect. Downstream pharmacology may transform occupancy into response nonlinearly.
- Receptor dynamics may matter. Receptor synthesis, internalization, degradation, and trafficking can make target availability time-dependent.
- Multiple ligands may compete. Other endogenous or exogenous ligands can alter receptor occupancy.
19. Where Are Receptor Occupancy Models Used?
Receptor occupancy models can be useful across several stages of drug development and quantitative pharmacology.
| Application | Role of occupancy modeling |
|---|---|
| Target engagement | Relate drug exposure to the fraction of target bound |
| Dose selection | Explore whether proposed exposure levels correspond to specified target engagement |
| Translational modeling | Connect preclinical binding information with clinical exposure |
| Biomarker interpretation | Relate concentration to molecular or cellular measures of target engagement |
| PK/PD modeling | Provide a mechanistic intermediate between concentration and effect |
| Drug combinations | Represent competitive interactions when compounds share a target |
| Imaging studies | Interpret radioligand or molecular-imaging measurements of target binding |
20. A Practical Receptor Occupancy Modeling Workflow
- Define the target. Specify the receptor, enzyme, transporter, or other molecular target being modeled.
- Define the relevant concentration. Determine whether free plasma, whole-blood, tissue, or another concentration is the appropriate driver.
- Characterize affinity. Obtain an appropriate estimate of \(K_D\) or another binding parameter from relevant experimental evidence.
- Choose the binding model. Decide whether a simple equilibrium model is sufficient or whether competition, multiple sites, or binding kinetics must be represented.
- Connect the model to PK. Use observed or model-predicted concentration-time profiles as the exposure input.
- Predict occupancy. Calculate the time-varying fraction of target occupied.
- Evaluate target-engagement data. Compare model predictions with molecular, imaging, biomarker, or other target-engagement measurements when available.
- Link occupancy to effect. If appropriate, add a downstream PD model rather than assuming occupancy and effect are identical.
- Assess uncertainty. Propagate uncertainty in PK parameters, affinity, free concentration, and other model components into occupancy predictions.
- Use the model for simulation. Explore how dose, schedule, exposure, affinity, and other parameters influence predicted target engagement.
21. Key Takeaways
- Receptor occupancy models describe how drug concentration translates into the fraction of receptors occupied.
- The classical one-site equilibrium model is \(f_{\mathrm{occ}}=C/(K_D+C)\).
- \(K_D\) is the equilibrium dissociation constant and, in the simple model, corresponds to the concentration producing 50% receptor occupancy.
- Receptor occupancy is saturable because the number of available binding sites is finite.
- Fractional occupancy and the absolute amount of receptor-bound drug are different quantities.
- \(K_D\) and \(EC_{50}\) describe different concepts and should not automatically be treated as interchangeable.
- Occupancy does not necessarily equal pharmacologic effect; downstream signaling can create a nonlinear occupancy-effect relationship.
- When binding is fast relative to changes in concentration, a PK concentration-time profile can be transformed into a time-varying occupancy profile.
- When binding kinetics are important, dynamic models using \(k_{\mathrm{on}}\) and \(k_{\mathrm{off}}\) may be more appropriate than an equilibrium model.
- Competitive binding models can account for the effects of multiple ligands interacting with the same target.
- Receptor occupancy models provide a useful mechanistic bridge between PK exposure and target engagement.
- Model complexity should reflect the biological question and the information contained in the available data.
Where to Go Next
A natural progression is to study target engagement models, followed by effect-compartment models, indirect response models, receptor turnover, binding kinetics, mechanistic PK/PD models, and exposure-biomarker-response relationships.
The next tutorial can build directly on receptor occupancy by showing how target binding becomes a quantitative intermediate between pharmacokinetics and downstream pharmacodynamic response.